Eiger BioPharmaceuticals has filed for bankruptcy after its long-running financial problems and R&D setbacks came to a head.
The Palo Alto, CA-based company marketed Zokinvy (lonafarnib), the first ever treatment for premature ageing condition Hutchinson-Gilford progeria syndrome, one of the rarest diseases in the world